You can buy or sell CDMO and other stocks, options, ETFs, and crypto commission-free!
Avid Bioservices, Inc. engages in the commercial manufacturing focused on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. Read More The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
52 Week High
52 Week Low
Simply Wall St8h
The Avid Bioservices (NASDAQ:CDMO) Share Price Is Up 71% And Shareholders Are Holding On
Passive investing in index funds can generate returns that roughly match the overall market. But one can do better than that by picking better than average stocks (as part of a diversified portfolio). To wit, the Avid Bioservices, Inc. (NASDAQ:CDMO) share price is 71% higher than it was a year ago, much better than the market return of around 5.8% (not including dividends) in the same period. So that should have shareholders smiling. Also impressive, the stock is up 50% over three years, making long term sh...
Yahoo FinanceMar 21
Edited Transcript of PPHM earnings conference call or presentation 11-Mar-19 8:30pm GMT
Q3 2019 Avid Bioservices Inc Earnings Call Tustin Mar 21, 2019 (Thomson StreetEvents) -- Edited Transcript of Avid Bioservices Inc earnings conference call or presentation Monday, March 11, 2019 at 8:30:00pm GMT TEXT version of Transcript Scroll to continue with content Ad ================================================================================ Corporate Participants ================================================================================ * Daniel R. Hart Avid Bioservices, Inc. - CFO...
Seeking AlphaMar 11
Avid Bioservices, Inc. (CDMO) CEO Roger Lias on Q3 2019 Results - Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ:CDMO) Q3 2019 Results Earnings Conference Call March 11, 2019 4:30 PM ET Company Participants Tim Brons - Investor Relations Roger Lias - President and Chief Executive Officer Daniel Hart - Chief Financial Officer Conference Call Participants Joseph Pantginis - H.C. Wainwright Paul Knight - Janney Montgomery Steven Schwartz - First Analyst Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservices’ Third Quarter 2019 Financial Results Conference Cal...
-$0.07 per share
-$0.05 per share